期刊
JOURNAL OF LEUKOCYTE BIOLOGY
卷 67, 期 1, 页码 109-116出版社
FEDERATION AMER SOC EXP BIOL
DOI: 10.1002/jlb.67.1.109
关键词
Alzheimer's disease; complement; Fc receptor; CR1; neurodegenerative disease; central nervous system
资金
- NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035144] Funding Source: NIH RePORTER
- NIA NIH HHS [AG-00096] Funding Source: Medline
- NINDS NIH HHS [NS-35144] Funding Source: Medline
Microglial activation has been associated with several degenerative diseases of the central nervous system (CNS), One consequence of activation is the induction of a more efficient phagocytic response, and it is therefore important to determine what factors regulate microglial phagocytosis and whether this capacity influences the progression of neurodegenerative changes. Previous studies have demonstrated that complement component Clq enhances Pc receptor- and CR1-mediated phagocytosis in cells of the myeloid lineage via a cell surface receptor, C1qR(P). Because Clq has been found in the area of lesions in several degenerative CNS diseases, the current investigations were carried out to characterize the effects of Clq on microglial phagocytosis. Neonatal rat microglia were shown to express C1qR(P) as assessed by flow cytometry and immunocytochemistry, Interaction of these cells with substrate-bound Clq was shown to enhance both FcR- and CR1-mediated phagocytosis two- to fourfold. In addition, introduction of an antibody raised against the carboxy-terminal, cytoplasmic domain of C1qR(P) into microglia by electroporation markedly diminished the ability of Clq to enhance uptake of IgG-coated targets, whereas nonspecific IgG had no such effect. These results suggest that Clq in areas of active degeneration may promote the phagocytic capacity of microglia via interaction with microglial C1qR(P).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据